Cargando…
Prevalence of transient congenital hypothyroidism in central part of Iran
BACKGROUND: Congenital hypothyroidism (CH) considered a common endocrine disorder in Iran. We report the epidemiologic findings of CH screening program in Isfahan, seven years after its development, regarding the prevalence of transient CH (TCH) and its screening properties comparing with permanent...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3872610/ https://www.ncbi.nlm.nih.gov/pubmed/24379847 |
_version_ | 1782296989085466624 |
---|---|
author | Ghasemi, Mahmoud Hashemipour, Mahin Hovsepian, Silva Heiydari, Kamal Sajadi, Ali Hadian, Rezvaneh Mansourian, Marjan Mirshahzadeh, Naghme Dalvi, Marzie |
author_facet | Ghasemi, Mahmoud Hashemipour, Mahin Hovsepian, Silva Heiydari, Kamal Sajadi, Ali Hadian, Rezvaneh Mansourian, Marjan Mirshahzadeh, Naghme Dalvi, Marzie |
author_sort | Ghasemi, Mahmoud |
collection | PubMed |
description | BACKGROUND: Congenital hypothyroidism (CH) considered a common endocrine disorder in Iran. We report the epidemiologic findings of CH screening program in Isfahan, seven years after its development, regarding the prevalence of transient CH (TCH) and its screening properties comparing with permanent CH (PCH). MATERIALS AND METHODS: In this cross-sectional study, children with primary diagnosis of CH were studied. Considering screening and follow-up lab data and the decision of pediatric endocrinologists, the final diagnosis of TCH was determined. RESULTS: A total of 464,648 neonates were screened. The coverage percent of the CH screening and recall rate was 98.9 and 2.1%, respectively. Out of which, 1,990 neonates were diagnosed with primary CH. TCH was diagnosed in 1,580 neonates. The prevalence of TCH was 1 in 294 live births. 79.4% of patients with primary CH had TCH. Mean of screening (54.7 ± 59.0 in PCH vs 21.8 ± 28.9 in TCH), recall (56.5 ± 58.8 in PCH vs 36.6 ± 45.0 in TCH), and thyroid stimulating hormone (TSH) and mean of TSH before (2.0 ± 2.9 in PCH vs 1.6 ± 1.6 in TCH) and after (37.7 ± 29.5 in PCH vs 4.3 ± 1.9 in TCH) discontinuing treatment at 3 years of age was significantly higher in PCH than TCH (P < 0.0000). CONCLUSION: The higher rate of CH in Isfahan is mainly due to the transient form of the disease. Further studies for evaluating the role of other environmental, autoimmune and/or genetic factors in the pathophysiology of the disease is warranted. |
format | Online Article Text |
id | pubmed-3872610 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | Medknow Publications & Media Pvt Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-38726102013-12-30 Prevalence of transient congenital hypothyroidism in central part of Iran Ghasemi, Mahmoud Hashemipour, Mahin Hovsepian, Silva Heiydari, Kamal Sajadi, Ali Hadian, Rezvaneh Mansourian, Marjan Mirshahzadeh, Naghme Dalvi, Marzie J Res Med Sci Original Article BACKGROUND: Congenital hypothyroidism (CH) considered a common endocrine disorder in Iran. We report the epidemiologic findings of CH screening program in Isfahan, seven years after its development, regarding the prevalence of transient CH (TCH) and its screening properties comparing with permanent CH (PCH). MATERIALS AND METHODS: In this cross-sectional study, children with primary diagnosis of CH were studied. Considering screening and follow-up lab data and the decision of pediatric endocrinologists, the final diagnosis of TCH was determined. RESULTS: A total of 464,648 neonates were screened. The coverage percent of the CH screening and recall rate was 98.9 and 2.1%, respectively. Out of which, 1,990 neonates were diagnosed with primary CH. TCH was diagnosed in 1,580 neonates. The prevalence of TCH was 1 in 294 live births. 79.4% of patients with primary CH had TCH. Mean of screening (54.7 ± 59.0 in PCH vs 21.8 ± 28.9 in TCH), recall (56.5 ± 58.8 in PCH vs 36.6 ± 45.0 in TCH), and thyroid stimulating hormone (TSH) and mean of TSH before (2.0 ± 2.9 in PCH vs 1.6 ± 1.6 in TCH) and after (37.7 ± 29.5 in PCH vs 4.3 ± 1.9 in TCH) discontinuing treatment at 3 years of age was significantly higher in PCH than TCH (P < 0.0000). CONCLUSION: The higher rate of CH in Isfahan is mainly due to the transient form of the disease. Further studies for evaluating the role of other environmental, autoimmune and/or genetic factors in the pathophysiology of the disease is warranted. Medknow Publications & Media Pvt Ltd 2013-08 /pmc/articles/PMC3872610/ /pubmed/24379847 Text en Copyright: © Journal of Research in Medical Sciences http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Article Ghasemi, Mahmoud Hashemipour, Mahin Hovsepian, Silva Heiydari, Kamal Sajadi, Ali Hadian, Rezvaneh Mansourian, Marjan Mirshahzadeh, Naghme Dalvi, Marzie Prevalence of transient congenital hypothyroidism in central part of Iran |
title | Prevalence of transient congenital hypothyroidism in central part of Iran |
title_full | Prevalence of transient congenital hypothyroidism in central part of Iran |
title_fullStr | Prevalence of transient congenital hypothyroidism in central part of Iran |
title_full_unstemmed | Prevalence of transient congenital hypothyroidism in central part of Iran |
title_short | Prevalence of transient congenital hypothyroidism in central part of Iran |
title_sort | prevalence of transient congenital hypothyroidism in central part of iran |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3872610/ https://www.ncbi.nlm.nih.gov/pubmed/24379847 |
work_keys_str_mv | AT ghasemimahmoud prevalenceoftransientcongenitalhypothyroidismincentralpartofiran AT hashemipourmahin prevalenceoftransientcongenitalhypothyroidismincentralpartofiran AT hovsepiansilva prevalenceoftransientcongenitalhypothyroidismincentralpartofiran AT heiydarikamal prevalenceoftransientcongenitalhypothyroidismincentralpartofiran AT sajadiali prevalenceoftransientcongenitalhypothyroidismincentralpartofiran AT hadianrezvaneh prevalenceoftransientcongenitalhypothyroidismincentralpartofiran AT mansourianmarjan prevalenceoftransientcongenitalhypothyroidismincentralpartofiran AT mirshahzadehnaghme prevalenceoftransientcongenitalhypothyroidismincentralpartofiran AT dalvimarzie prevalenceoftransientcongenitalhypothyroidismincentralpartofiran |